Steady capillary-gravity waves on deep water

The properties of capillary-gravity waves of permanent form on deep water are studied. Two different formulations to the problem are given. The theory of simple bifurcation is reviewed. For small amplitude waves a formal perturbation series is used. The Wilton ripple phenomenon is reexamined and shown to be associated with a bifurcation in which a wave of permanent form can double its period. It is shown further that Wilton's ripples are a special case of a more general phenomenon in which bifurcation into subharmonics and factorial higher harmonics can occur. Numerical procedures for the calculation of waves of finite amplitude are developed. Bifurcation and limit lines are calculated. Pure and combination waves are continued to maximum amplitude. It is found that the height is limited in all cases by the surface enclosing one or more bubbles. Results for the shape of gravity waves are obtained by solving an integra-differential equation. It is found that the family of solutions giving the waveheight or equivalent parameter has bifurcation points. Two bifurcation points and the branches emanating from them are found specifically, corresponding to a doubling and tripling of the wavelength. Solutions on the new branches are calculated.

Delivery of Targeted Nanoparticles Across the Blood-Brain Barrier Using a Detachable Targeting Ligand

Chronic diseases of the central nervous system are poorly treated due to the inability of most therapeutics to cross the blood-brain barrier. The blood-brain barrier is an anatomical and physiological barrier that severely restricts solute influx, including most drugs, from the blood to the brain. One promising method to overcome this obstacle is to use endogenous solute influx systems at the blood-brain barrier to transport drugs. Therapeutics designed to enter the brain through transcytosis by binding the transferrin receptor, however, are restricted within endothelial cells. The focus of this work was to develop a method to increase uptake of transferrin-containing nanoparticles into the brain by overcoming these restrictive processes.

To accomplish this goal, nanoparticles were prepared with surface transferrin molecules bound through various liable chemical bonds. These nanoparticles were designed to shed the targeting molecule during transcytosis to allow increased accumulation of nanoparticles within the brain.

Transferrin was added to the surface of nanoparticles through either redox or pH sensitive chemistry. First, nanoparticles with transferrin bound through disulfide bonds were prepared. These nanoparticles showed decreased avidity for the transferrin receptor after exposure to reducing agents and increased ability to enter the brain in vivo compared to those lacking the disulfide link.

Next, transferrin was attached through a chemical bond that cleaves at mildly acidic pH. Nanoparticles containing a cleavable link between transferrin and gold nanoparticle cores were found to both cross an in vitro model of the blood-brain barrier and accumulate within the brain in significantly higher numbers than similar nanoparticles lacking the cleavable bond. Also, this increased accumulation was not seen when using this same strategy with an antibody to transferrin receptor, indicating that behavior of nanoparticles at the blood-brain barrier varies depending on what type of targeting ligand is used.

Finally, polymeric nanoparticles loaded with dopamine and utilizing a superior acid-cleavable targeting chemistry were investigated as a potential treatment for Parkinson’s disease. These nanoparticles were capable of increasing dopamine quantities in the brains of healthy mice, highlighting the therapeutic potential of this design. Overall, this work describes a novel method to increase targeted nanoparticle accumulation in the brain.